Close

Auriga Maintains a 'Buy' on Omnicell (OMCL); Still Buyers Near-Term, but 2012 Contains Headwinds

September 21, 2011 6:57 AM EDT
Get Alerts OMCL Hot Sheet
Price: $27.04 -1.42%

Rating Summary:
    9 Buy, 8 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 11 | Down: 12 | New: 9
Join SI Premium – FREE
Auriga maintains a 'Buy' on Omnicell (NASDAQ: OMCL) price target of $19.00.

Auriga analyst says, "We continue to recommend Omnicell at current levels with approximately 25% upside to our $19 price target. The stock has traded relatively flat in the latest three months despite a volatile market and we are comfortable that OMCL will deliver results near the top end of guidance for the year. That said, we believe another large deal or two (equivalent to or greater than last month's University of Chicago announcement) is a requirement before year-end in order for us to gain comfort with FY12 consensus. The high penetration of Omnicell's base business, sustained high unemployment and continuing pressures on hospital spending keep us cautious with respect to FY12 growth."

For more ratings news on Omnicell click here and for the rating history of Omnicell click here.

Shares of Omnicell closed at $15.00 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments

Related Entities

Auriga